1. Home
  2. UPBD vs CLDX Comparison

UPBD vs CLDX Comparison

Compare UPBD & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPBD
  • CLDX
  • Stock Information
  • Founded
  • UPBD 1986
  • CLDX N/A
  • Country
  • UPBD United States
  • CLDX United States
  • Employees
  • UPBD N/A
  • CLDX N/A
  • Industry
  • UPBD Diversified Commercial Services
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • UPBD Consumer Discretionary
  • CLDX Health Care
  • Exchange
  • UPBD Nasdaq
  • CLDX Nasdaq
  • Market Cap
  • UPBD 1.6B
  • CLDX 1.3B
  • IPO Year
  • UPBD 1995
  • CLDX 2008
  • Fundamental
  • Price
  • UPBD $23.96
  • CLDX $18.15
  • Analyst Decision
  • UPBD Buy
  • CLDX Buy
  • Analyst Count
  • UPBD 4
  • CLDX 8
  • Target Price
  • UPBD $37.00
  • CLDX $54.29
  • AVG Volume (30 Days)
  • UPBD 571.4K
  • CLDX 749.8K
  • Earning Date
  • UPBD 05-01-2025
  • CLDX 05-05-2025
  • Dividend Yield
  • UPBD 6.51%
  • CLDX N/A
  • EPS Growth
  • UPBD N/A
  • CLDX N/A
  • EPS
  • UPBD 2.21
  • CLDX N/A
  • Revenue
  • UPBD $4,320,564,000.00
  • CLDX $7,020,000.00
  • Revenue This Year
  • UPBD $8.46
  • CLDX N/A
  • Revenue Next Year
  • UPBD $6.87
  • CLDX $27.01
  • P/E Ratio
  • UPBD $10.84
  • CLDX N/A
  • Revenue Growth
  • UPBD 8.22
  • CLDX 1.99
  • 52 Week Low
  • UPBD $23.35
  • CLDX $17.63
  • 52 Week High
  • UPBD $38.72
  • CLDX $47.00
  • Technical
  • Relative Strength Index (RSI)
  • UPBD 37.96
  • CLDX 34.76
  • Support Level
  • UPBD $24.01
  • CLDX $19.48
  • Resistance Level
  • UPBD $25.60
  • CLDX $20.38
  • Average True Range (ATR)
  • UPBD 0.71
  • CLDX 1.04
  • MACD
  • UPBD 0.09
  • CLDX -0.02
  • Stochastic Oscillator
  • UPBD 27.11
  • CLDX 12.32

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: